Among the overall studies, 17 (9,10,12,13,15,18–20,22–26,28,29,31) further evaluated the putative EPHX1 enzyme activity and COPD risk using the method described by Hassett et al(8). This evidence concerns the gene EPHX1 and chronic obstructive pulmonary disease.